Search results for "Deoxycholic acid"

showing 10 items of 45 documents

The Measurement of Enzyme Activities in the Resting Human Polymorphonuclear Leukocyte — Critical Estimate of a Method

1993

As a system for study, the isolated human polymorphonuclear leukocyte combines the advantages of a quasi-non-invasive preparation with a nearly complete complement of enzymes of carbohydrate and energy metabolism. However, small sample volumes and, in some cases, very low enzyme activities make high demands on sample processing, storage, and performance of continuous measurements, if the enzyme activities are to be measured with acceptable reproducibility. In the presented study several aspects of homogenization, storage, and continuous measurement were scrutinized, to identify critical steps and consider ways of optimizing the method. Polymorphonuclear leukocytes were separated from the bl…

NeutrophilsCitric Acid CycleeducationClinical BiochemistryTransketolaseGranulocytePhotometrychemistry.chemical_compoundCentrifugation Density GradientmedicineHumansCitrate synthaseHexosephosphatesDifferential centrifugationchemistry.chemical_classificationStaining and LabelingbiologyBiochemistry (medical)Deoxycholic acidReproducibility of ResultsGeneral MedicineEnzyme assayEnzymesmedicine.anatomical_structureEnzymeBiochemistrychemistrybiology.proteinGlycolysisGlycogenHomogenization (biology)Clinical Chemistry and Laboratory Medicine
researchProduct

Novel deoxycholic acid alkylamide-phenylurea-derived organogelators

2010

Abstract Three monomeric and three dimeric deoxycholic acid (DCA) alkylamido-phenylurea derivatives are designed based on known gelators and are synthesized and characterized by 1 H and 13 C NMR spectroscopy, ESI-TOF mass spectrometry, and elemental analyses. Among them, a monomeric derivative forms supramolecular gels in CHCl 3 and chlorobenzene, whereas a dimeric derivative gels THF and higher 1-alkanols containing 7–10 carbons. The morphologies of their xerogels are studied by scanning electron microscopy (SEM). No signature of macroscopic chirality of the gels is visible.

Organic ChemistryDeoxycholic acidSupramolecular chemistryCarbon-13 NMRMass spectrometryBiochemistrychemistry.chemical_compoundMonomerchemistryChlorobenzeneDrug DiscoveryOrganic chemistryChirality (chemistry)SpectroscopyTetrahedron Letters
researchProduct

Primary biliary cirrhosis and hereditary hemorrhagic telangiectasia: When two rare diseases coexist

2013

Primary biliary cirrhosis is a slowly progressive cholestatic autoimmune liver disease that mainly affects middle- aged women with an estimated prevalence ranging from 6.7 to 402 cases per million. Hereditary hemorrhagic telangiectasia, or Rendu-Osler-Weber disease, is an autosomal dominant disorder characterized by angiodysplastic lesions (telangiectases and arteriovenous malformations) that can affect many organs, including liver, with a prevalence of 1-2 cases per 10000. We describe the coexistence, for the first time to our knowledge, of these two rare diseases in a 50-year old Caucasian woman. In this setting, the relevance of an accurate medical history, the role of liver histology an…

Pathologymedicine.medical_specialtySettore MED/12 - GastroenterologiaPrimary biliary cirrhosiHepatologybusiness.industryFocal nodular hyperplasiaCase ReportDiseaseTelangiectasesImmunostainingSettore MED/08 - Anatomia Patologicamedicine.diseaseUrsodeoxycholic acidPrimary biliary cirrhosisHereditary hemorragic telangiectasiaUrsodeoxycholic acidFocal nodular hyperplasiamedicineMedical historymedicine.symptomAutoimmune liver diseasebusinessTelangiectasiamedicine.drug
researchProduct

Modelling phase transition kinetics of chenodeoxycholic acid with the Runge–Kutta method

2009

Abstract The phase transition kinetics of two chenodeoxycholic acid polymorphic modifications— form I (stable at high temperature), form III (stable at low temperature) and the amorphous phase has been examined under various conditions of temperature and relative humidity. Form III conversion to form I was examined at high temperature conditions and was found to be non-spontaneous, requiring seed crystals for initiation. The formation kinetic model of form I was created incorporating the three-dimensional seed crystal growth, the phase transition rate proportion to the surface area of form I crystals, and the influence of the amorphous phase surface area changes with an empirical stage poin…

Phase transitionDifferential Thermal AnalysisSpectrophotometry InfraredDifferential equationClinical BiochemistryPharmaceutical ScienceThermodynamicsChenodeoxycholic AcidKinetic energyPhase TransitionAnalytical ChemistryReaction rate constantDrug StabilityX-Ray DiffractionDrug DiscoverySample preparationSpectroscopySeed crystalModels StatisticalCalorimetry Differential ScanningChemistryTemperatureKineticsRunge–Kutta methodsCrystallographyX-ray crystallographyCrystallizationJournal of Pharmaceutical and Biomedical Analysis
researchProduct

Deoxycholic Acid Methyl Ester — a Novel Bacterial Metabolite of Cholic Acid

1985

Summary Methyl deoxycholate was identified as a novel bacterial metabolite of cholate, produced anaerobically by strains of most saccharolytic Bacteroides species ( B. distasonis, B. eggerthii, B. fragilis, B. incommunis, B. thetaiotaomicron, B. uniformis, B. variabilis, B. vulgatus , and unnamed species). It was also detected with a few strains of Eubacterium and Lactobacillus species. Among 2476 freshly isolated human fecal cultures the frequency of carboxyl group esterification was comparable with that of 7α-dehydroxylation (92 versus 102 cultures). Both activities were, however, lost for unknown reasons after serial transfers. Two of ten mixed fecal cultures tested esterified 3α,7α- or …

biologyBile acidmedicine.drug_classMetaboliteDeoxycholic acidCholic acidbiology.organism_classificationApplied Microbiology and BiotechnologyMicrobiologyMicrobiologychemistry.chemical_compoundfluids and secretionschemistryBiochemistryLactobacillusmedicineEubacteriumBacteroidesEcology Evolution Behavior and SystematicsBacteriaSystematic and Applied Microbiology
researchProduct

Determination of cationic surfactants by capillary zone electrophoresis and micellar electrokinetic chromatography with deoxycholate micelles in the …

2000

Mixtures of the cationic surfactants benzalkonium chloride (BKC) and cetylpyridinium chloride (CPC) were quickly resolved and reproducibly and reliably determined by using background electrolytes (BGEs) containing 80 mM borate, pH 8.5, bile salts and large concentrations of an organic solvent. When the bile salt is present, the separation mechanism changes from capillary zone electrophoresis (CZE) to a mixed micellar electrokinetic chromatography (MEKC)-CZE, with predominant MEKC interactions, which lead to an excellent resolution of all the solutes, including the C12-C18 homologues of BKC and CPC. A BGE containing 50 mM sodium deoxycholate and 30% ethanol for an extreme resolution, or 20% …

chemistry.chemical_classificationChromatographyResolution (mass spectrometry)Organic ChemistryCationic polymerizationSalt (chemistry)General MedicineCetylpyridinium chlorideBiochemistryMicelleMicellar electrokinetic chromatographyAnalytical Chemistrychemistry.chemical_compoundBenzalkonium chlorideSurface-Active AgentsCapillary electrophoresischemistryCationsmedicineSolventsMicellesmedicine.drugChromatography Micellar Electrokinetic CapillaryDeoxycholic AcidJournal of chromatography. A
researchProduct

2021

Six bile acid alkyl amide derivatives were studied with respect to their gelation properties. The derivatives were composed of three different bile acids with hexyl or cyclohexyl side chains. The gelation behaviour of all six compounds were studied for 36 solvents with varying polarities. Gelation was observed mainly in aromatic solvents, which is characteristic for bile-acid-based low molecular weight gelators. Out of 108 bile acid-solvent combinations, a total of 44 gel systems were formed, 28 of which from lithocholic acid derivatives, only two from deoxycholic acid derivatives, and 14 from cholic acid derivatives. The majority of the gel systems were formed from bile acids with hexyl si…

chemistry.chemical_classificationLithocholic acidBile acidmedicine.drug_classDeoxycholic acidCholic acidGeneral Chemistrychemistry.chemical_compoundchemistryAmidePolymer chemistrySide chainmedicineMoietyAlkylChemistryOpen
researchProduct

Effect of tauroursodeoxycholic acid on bile acid-induced apoptosis in primary human hepatocytes

2000

Background/aims The accumulation of endogenous bile acids contributes to hepatocellular damage during cholestatic liver disease. To evaluate the potential role of apoptotic cell death due to increased concentrations of bile acids, primary human hepatocytes were treated with hydrophobic and hydrophilic bile acids. Because the Fas receptor–ligand system may mediate apoptosis in human liver cells, the effect of toxic bile acids on hepatocellular Fas receptor expression was evaluated. Materials and methods Primary human hepatocytes were incubated with 50 and 100 μM glycochenodeoxycholic acid (GCDCA) and co-incubated with equimolar concentrations of tauroursodeoxycholic acid (TUDCA). To evaluate…

medicine.medical_specialtyBile acidmedicine.drug_classClinical BiochemistryApoptotic DNA fragmentationTaurochenodeoxycholic acidTauroursodeoxycholic acidGeneral MedicineBiologyFas receptorBiochemistryMolecular biologyUrsodeoxycholic acidchemistry.chemical_compoundEndocrinologychemistryApoptosisInternal medicinemedicineGlycochenodeoxycholic acidmedicine.drugEuropean Journal of Clinical Investigation
researchProduct

Primary Biliary Cholangitis: advances in management and treatment of the disease

2017

Primary Biliary Cholangitis, previously known as Primary Biliary Cirrhosis, is a rare disease, which mainly affects women in their fifth to seventh decades of life. It is a chronic autoimmune disease characterized by a progressive damage of interlobular bile ducts leading to ductopenia, chronic cholestasis and bile acids retention. Even if the disease usually presents a long asymptomatic phase and a slow progression, in many patients it may progress faster toward cirrhosis and its complications. The 10Â year mortality is greater than in diseases such as human immunodeficiency virus/Hepatitis C Virus coinfection and breast cancer. Ursodeoxycholic acid is the only treatment available today, b…

medicine.medical_specialtyCholagogues and CholereticsCirrhosisPrimary Biliary CholangitisCholangitisDiseaseChenodeoxycholic AcidGastroenterologyEnd Stage Liver Disease03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePrimary biliary cirrhosisDuctopeniaAlkaline phosphatase; Budesonide; Fibrates; Obeticholic acid; Ursodeoxycholic acid; Hepatology; GastroenterologyMED/12 - GASTROENTEROLOGIAInternal medicineAlkaline phosphatasemedicineHumansFibrateSettore SECS-P/01 - Economia PoliticaBudesonideCholestasisHepatologyAlkaline phosphatase; Budesonide; Fibrates; Obeticholic acid; Ursodeoxycholic acidbusiness.industryGastroenterologyObeticholic acidHepatologymedicine.diseaseUrsodeoxycholic acidchemistryUrsodeoxycholic acid030220 oncology & carcinogenesisObeticholic acidDisease Progression030211 gastroenterology & hepatologyDrug Therapy CombinationbusinessFibratesbiologicalRare diseasemedicine.drug
researchProduct

Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis

2000

Aim: To establish the efficacy of combination therapy with ursodeoxycholic acid (UDCA) and colchicine in patients with symptomatic primary biliary cirrhosis (PBC), defined by the presence of liver cirrhosis, pruritus or bilirubin exceeding 2 mg/mL. Methods: A total of 90 patients were randomly assigned to ursodeoxycholic acid 500 mg/daily plus placebo (UDCA group, n=44), or ursodeoxycholic acid at the same dosage plus colchicine, 1 mg/daily (UDCA/C group, n=46). The two groups were comparable for age, sex, stage of disease, severity of pruritus, bilirubin, and Mayo score. All patients underwent clinical, ultrasonographic, and biochemical examinations at entry and then every 6 months up to 3…

medicine.medical_specialtyCirrhosisHepatologymedicine.diagnostic_testbusiness.industryBiliary cirrhosisGastroenterologyPlacebo-controlled studymedicine.diseasePlaceboGastroenterologyUrsodeoxycholic acidPrimary biliary cirrhosisCholestasisLiver biopsyInternal medicinemedicinePharmacology (medical)businessmedicine.drugAlimentary Pharmacology & Therapeutics
researchProduct